| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/13/2007 | US7175997 BMP-11 compositions |
| 02/13/2007 | US7175994 Lactacystin, a peptidyl aldehyde, or a peptidyl epoxy ketone inhibits proteasomal activity; epidermal growth factor, a fibroblast growth factor, a platelet-derived growth factor, a transforming growth factor, a parathyroid hormone, etc for promoting skin tissue growth, an excipient |
| 02/13/2007 | US7175988 Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
| 02/13/2007 | US7175849 Polypeptide for use in the treatment of viral disorders |
| 02/13/2007 | US7175848 Used to produce immunotoxins (ITs) and cytokines with a reduced ability to promote vascular leak syndrome (VLS) |
| 02/13/2007 | US7175844 Administering an agent that inhibits a component of the VEGF signal transduction pathway; agent decreases a connective tissue growth factor (CTGF) activity in the tissue of the subject. |
| 02/13/2007 | US7175842 Methods of modulating hair growth |
| 02/13/2007 | US7175840 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 02/13/2007 | US7175839 Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy |
| 02/13/2007 | US7175838 Administering promoter of T-cell expansion and inducer of CD40 stimulation in synergistically effective amounts to treat or prevent pathologic state in mammal; cancer therapy |
| 02/13/2007 | US7175828 Modulators of β-amyloid peptide aggregation comprising D-amino acids |
| 02/13/2007 | US7175679 Modulating expression of a gene in a cell comprising providing the cell with a signaling molecule comprising a peptide |
| 02/13/2007 | US7175658 Coated with fibronectin on the interior surface, and having endothelial cells genetically altered to express a full-length human fibulin-5 polypeptide seeded and cultured on the interior surface of the tubular element; better adhesion of cells to the graft |
| 02/13/2007 | US7175647 Repair of ruptured membrane by injection of naturally occurring protein in amniotic fluid sac |
| 02/13/2007 | CA2510981C Fibrin sealant compositions and methods for utilizing same |
| 02/13/2007 | CA2254759C Inhibitors of prenyl transferases |
| 02/13/2007 | CA2233501C Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms |
| 02/13/2007 | CA2219947C Monoclonal antibody reactive to human cetp and assay method for human cetp |
| 02/13/2007 | CA2124958C Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 02/13/2007 | CA2084987C Nucleic acid ligands |
| 02/08/2007 | WO2007016643A2 A method for extending longevity using npc1l1 antagonists |
| 02/08/2007 | WO2007016600A2 Method of preserving the function of insulin-producing cells |
| 02/08/2007 | WO2007016593A2 Antifungal peptides and methods of use thereof |
| 02/08/2007 | WO2007016542A2 Her-2 blocking bifunctional targeted peptides |
| 02/08/2007 | WO2007016476A2 Hepatitis c serine protease inhibitors and uses therefor |
| 02/08/2007 | WO2007016441A1 Macrocyclic peptides as hcv ns3 protease inhibitors |
| 02/08/2007 | WO2007016364A2 Peptide deformylase inhibitors |
| 02/08/2007 | WO2007016185A2 Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination |
| 02/08/2007 | WO2007016073A1 Pharmaceutical emulsion compositions comprising cyclosporin |
| 02/08/2007 | WO2007016018A2 Improved botulinum toxin compositions |
| 02/08/2007 | WO2007015918A2 Novel biologically active peptides and their new uses |
| 02/08/2007 | WO2007015855A1 Hcv ns3 protease inhibitors |
| 02/08/2007 | WO2007015824A2 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 02/08/2007 | WO2007015787A1 Hcv ns3 protease inhibitors |
| 02/08/2007 | WO2007015782A1 Molecular variant fibrinogen fusion proteins |
| 02/08/2007 | WO2007015638A2 Methods and means for controlling the endocytosis and subsequent degradation of a cell surface protein |
| 02/08/2007 | WO2007015546A1 Mesenchymal stem cell inducer, tissue regeneration promoter and method of preparing mesenchymal stem cell |
| 02/08/2007 | WO2007015540A1 Cytotoxic t-cell epitope peptide and use thereof |
| 02/08/2007 | WO2007015171A2 Method of treating patients with a mucinous glycoprotein (muc-1) vaccine |
| 02/08/2007 | WO2007015170A2 Synapse-specific proteins in glomeruli |
| 02/08/2007 | WO2007015069A2 Compositions for ameliorating a reduced higher brain function resulting from organic brain lesions |
| 02/08/2007 | WO2007014946A1 Substituted ethane-1,2-diamines for the treatment of alzheimer's disease ii |
| 02/08/2007 | WO2007014943A2 Therapy for neurological diseases |
| 02/08/2007 | WO2007014926A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014925A1 Macrocylic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014924A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014920A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014919A1 Macrocylic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014896A1 Processes for the manufacture of sterilized pancreatin powder |
| 02/08/2007 | WO2007014798A2 Use of the globular domain of acrp30 for the preparation of a medicament for the prevention and/or treatment of thrombosis-related diseases |
| 02/08/2007 | WO2007014771A1 Stimulators of factor x activated (fxa) as new topical antihemorrhagic agents |
| 02/08/2007 | WO2007014497A1 A composition comprising silver nanoparticles and the use thereof |
| 02/08/2007 | WO2007014476A1 Pharmaceutical composition containing indometacin and/or acemetacin |
| 02/08/2007 | WO2006133276A3 Methods for dissolving cystine stones and reducing cystine in urine |
| 02/08/2007 | WO2006128471A3 A solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids |
| 02/08/2007 | WO2006127452A3 Methods and compositions for modulating the activity of peptidases in macrophage and macrophage-like cells |
| 02/08/2007 | WO2006124892A3 Modulators of alpha-synuclein toxicity |
| 02/08/2007 | WO2006114774A3 Pyrimidine derivatives and their use as p2y12 receptor antagonists |
| 02/08/2007 | WO2006088576A3 Polypeptide formulations and methods for making, using and characterizing them |
| 02/08/2007 | WO2006085700A3 Pharmaceutical agents for preventing metastasis of cancer |
| 02/08/2007 | WO2006085631A3 Novel method for treating chronic severe heart failure by using insulin-like growth factor-1 (igf-1) |
| 02/08/2007 | WO2006067506A3 Hiv resistance genes |
| 02/08/2007 | WO2006063837A3 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
| 02/08/2007 | WO2006048633A3 Combination comprising zd6474 and an antiandrogen |
| 02/08/2007 | WO2006042252A3 Viral complement control proteins for eye disorders |
| 02/08/2007 | WO2006031375A3 Use of intradiscally administered autologous cells producing type i interferon for the treatment of degenerative disc disease |
| 02/08/2007 | WO2006026717A3 Method and device for diagnosing and treating insulin-like growth factor deficiency disorders |
| 02/08/2007 | WO2006021954A3 Peptide inhibitors for mediating stress responses |
| 02/08/2007 | WO2005122379A3 Alpha-4 beta-1 integrin ligands for imaging and therapy |
| 02/08/2007 | WO2005110468A3 Treatment of insulin resistance/metabolic syndrome to alleviate the risks of dementia |
| 02/08/2007 | WO2005032453A3 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 02/08/2007 | WO2004044124A3 Identification of oligoadenylate synthetase-like genes |
| 02/08/2007 | WO2003068934A3 Chimeric molecules for cleavage in a treated host |
| 02/08/2007 | WO2003059267A3 SELECTIVE 11β-HSD INHIBITORS AND METHODS FOR USE THEREOF |
| 02/08/2007 | US20070033669 Semaphorin gene family |
| 02/08/2007 | US20070032643 Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same |
| 02/08/2007 | US20070032642 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070032638 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain |
| 02/08/2007 | US20070032636 Chimeric retroviral Gag genes and screening assays |
| 02/08/2007 | US20070032635 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 02/08/2007 | US20070032457 Combination therapy for cancer treatment |
| 02/08/2007 | US20070032446 Gapped 2' modified oligonucleotides |
| 02/08/2007 | US20070032445 Antisense IAP nucleobase oligomers and uses thereof |
| 02/08/2007 | US20070032443 Therapy for Alzheimer's disease |
| 02/08/2007 | US20070032442 Vector utilizing ribonuclease reductase UTR and use for inhibiting neoplastic cells |
| 02/08/2007 | US20070032441 treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 02/08/2007 | US20070032440 Oligonucleotides directed against a survivin gene and use thereof |
| 02/08/2007 | US20070032437 Iap binding compounds |
| 02/08/2007 | US20070032436 Pharmaceutical formulations |
| 02/08/2007 | US20070032435 Pharmaceutical formulations |
| 02/08/2007 | US20070032434 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 02/08/2007 | US20070032433 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 02/08/2007 | US20070032432 Is able to specifically bind IL-6R and compete for the binding of IL-6 to IL-6R, to block IL-6-induced signal transduction and therefore effectively inhibits IL-6-mediated antiapoptosis and angiogenesis, and further inhibits IL-6-mediated tumor growth. |
| 02/08/2007 | US20070032431 laminin binding site |
| 02/08/2007 | US20070032430 which resemble G amphipathic helix of apolipoprotein J; atherosclerosis; stents; catheters |
| 02/08/2007 | US20070032429 Methods of using retro-inverso peptides derived from interleukin-6 |
| 02/08/2007 | US20070032428 Novel antimicrobial agents |
| 02/08/2007 | US20070032427 Methods and compositions for preserving the viability of photoreceptor cells |
| 02/08/2007 | US20070032426 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |